KL2 Training Program

Current & Past Scholars

The following are brief biographies of the scholars selected for each award year. As you can see, they represent broad disciplinary diversity and bring impressive and relevant training and experience to the CASE/Cleveland Clinic CTSC KL2.

Cohort 1 (2005) | Cohort 2 (2006) | Cohort 3 (2007) | Cohort 4 (2008) | Cohort 5 (2009)
| Cohort 6 (2010) | Cohort 7 (2011) | Cohort 8 (2012) | Cohort 9 (2013) | Cohort 10 (2014) | Cohort 11 (2015) | Cohort 12 (2016)

Cohort 11 (2015)

Mohamed Abazeed, MD, PhD
Mohamed Abazeed, MD, PhDDr. Abazeed received his BS, MD, and PhD (Biological Chemistry) degrees from the University of Michigan. He then completed his residency in Radiation Oncology at Harvard, where he was a B. Leonard Holman Fellow with a research emphasis on translational genomic sciences. He joined the Cleveland Clinic's Radiation Oncology and Translational Oncology Departments in 2013. Dr. Abazeed has been the successful recipient of several institutional and foundation grants, an invited speaker for the Case Comprehensive Cancer Center Scientific Retreat and Seminar Series, a recipient of the ASTRO Annual Meeting Resident Recognition Award in Biology (2012), and the ASTRO Translational Science Abstract Award in Biology (2015).  He will be studying the precision targeting of therapeutic resistance in non-small cell lung cancer.

Stefanie Avril
Dr. Stefanie AvrilDr. Stefanie Avril received her medical degree from the Technical University Munich, Germany, following training at the University of Caen, France, Cornell Medical School, New York, Harvard Medical School, Boston, and University Hospital Zurich, Switzerland. Her scientific career started with several studies on prediction of treatment response in ovarian and breast cancer using FDG-PET molecular imaging, followed by studies on histopathologic and molecular biomarkers of treatment response and intratumoral heterogeneity in breast and ovarian cancer. She is the recipient of several prestigious scholarships and research awards. After completing a residency in pathology at the Technical University Munich, Germany and a postdoctoral research fellowship at the University of Cambridge, UK, Dr. Avril joined CWRU/ UHCMC in 2014 as an assistant professor of pathology. Her research is focused on gynecologic oncology and breast cancer, with a specific interest in the tumor immune micro! environment and studying novel immunotherapeutic approaches to improve treatment of HER2-positive breast cancer.

Nicholas Schiltz, PhD
Nicholas Schiltz, PhDDr. Schiltz received his BS in Quantitative Economics & BA in Political Science from Miami University of Ohio and earned his PhD in Epidemiology & Biostatistics at CWRU. He is currently a research scientist in the department of Epidemiology & Biostatistics. Dr. Schiltz was awarded the Young Investigator Award from the American Epilepsy Society. His current research interests have focused on using large databases to study health outcomes and policy in people with multiple chronic conditions (MCC). His project seeks to develop and apply state-of-the-art data mining methods to better understand the epidemiology of the MCC population and to predict health care costs and outcomes. In addition, he plans to use mathematical modeling to test the impact of changes in health policy on access to care and health outcomes in the MCC population. The hope is that the findings will lead to the development of more comprehensive and personalized approaches to care management of patients with multiple chronic conditions. 

Jennifer Sweet, MD
Jennifer Sweet, MDDr. Sweet received her BS in Premedical studies and French from the University of Michigan. She earned her MD at Georgetown University where she also completed her Neurological Surgery residency. Dr. Sweet then came to UHCMC for her Stereotactic and Functional Neurosurgery fellowship and has stayed on as faculty. She received a Neurological Institute Research Award from UHCMC. Dr. Sweet's research involves the Deep Brain Stimulation of the Rostral Dorsal Cingulum Bundle for the Treatment of Bipolar Disorder. She hopes that this proposal will lead to a strategy to improve or even cure Bipolar Disorder for individuals who currently have no other options, and may also advance the surgical treatment of other psychiatric disorders by demonstrating how the utilization of tractography technology can assist in the identification of more precise targets for deep brain stimulation implantation.